medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 2

<< Back Next >>

Ann Hepatol 2017; 16 (2)

Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers

Bautista W, Lipschitz J, McKay A, Minuk GY

Language: English
References: 28
Page: 297-303
PDF size: 191.87 Kb.


ABSTRACT

Introduction and aim. The inability to distinguish cancer (CSCs) from normal stem cells (NSCs) has hindered attempts to identify safer, more effective therapies for hepatocellular carcinoma (HCC). The aim of this study was to document and compare cell membrane potential differences (PDs) of CSCs and NSCs derived from human HCC and healthy livers respectively and determine whether altered GABAergic innervation could explain the differences. Material and methods. Epithelial cell adhesion molecule (EpCAM) positive stem cells were isolated from human liver tissues by magnetic bead separations. Cellular PDs were recorded by microelectrode impalement of freshly isolated cells. GABAA receptor subunit expression was documented by reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescence. Results. CSCs were significantly depolarized (-7.0 ± 1.3 mV) relative to NSCs (-23.0 ± 1.4 mV, p ‹ 0.01). The depolarized state was associated with different GABAA receptor subunit expression profiles wherein phasic transmission, represented by GAGAA α3 subunit expression, was prevalent in CSCs while tonic transmission, represented by GABAA α6 subunit expression, prevailed in NSCs. In addition, GABAA subunits α3, β3, γ3 and δ were strongly expressed in CSCs while GABAA π expression was dominant in NSCs. CSCs and NSCs responded similarly to GABAA receptor agonists (ΔPD: 12.5 ± 1.2 mV and 11.0 ± 3.5 mV respectively). Conclusion. The results of this study indicate that CSCs are significantly depolarized relative to NSCs and these differences are associated with differences in GABAA receptor subunit expression. Together they provide new insights into the pathogenesis and possible treatment of human HCC.


REFERENCES

  1. Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. Int J Biochem Cell Biol 2012; 44: 2144-51.

  2. Garg M. Gain of antitumor functions and induction of differentiation in cancer stem cells contribute to complete cure and no relapse. Crit Rev Oncog 2009; 15: 65-90.

  3. Alison MR, Islam S, Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009; 217: 282-98.

  4. Matthews VB, Yeoh GC. Liver stem cells. IUBMB Life 2005; 57: 549-53.

  5. Bautista W, Perez-Alvarez V, Burczynski F, Raouf A, Klonisch T, Minuk G. Membrane potential differences and GABAA receptor expression in hepatic tumor and non-tumor stem cells. Can J Physiol Pharmacol 2014; 92: 85-91.

  6. Varju P, Katarova Z, Madarasz E, Szabo G. GABA signalling during development: new data and old questions. Cell Tissue Res 2001; 305: 239-46.

  7. Young SZ, Bordey A. GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda) 2009; 24: 171-85.

  8. Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem 2012; 287: 40224-31.

  9. Belelli D, Harrison NL, Maguire J, Macdonald RL, Walker MC, Cope DW. Extrasynaptic GABAA receptors: form, pharmacology, and function. J Neurosci 2009; 29: 12757-63.

  10. Kahan B, Magliocca J, Merriam F, Treff N, Budde M, Nelson J, Browning V, et al. Elimination of tumorigenic stem cells from differentiated progeny and selection of definitive endoderm reveals a Pdx1+ foregut endoderm stem cell lineage. Stem Cell Res 2011; 6: 143-57.

  11. Minuk GY, Bear CE, Sarjeant EJ. Sodium-independent, bicuculline- sensitive [3H]GABA biding to isolated rat hepatocytes. Am J Physiol 1987; 252: G642-G647.

  12. Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J, Shi X, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013; 11: 102.

  13. Li YH, Liu Y, Li D, Liu YH, Li F, Ju Q, Xie PL, et al. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. World J Gastroenterol 2012; 18: 2704-11.

  14. Kimura T, Ishikawa K, Sakasegawa Y, Teruya K, Sata T, Schatzl H, Doh-ura K. GABAA receptor subunit beta1 is involved in the formation of protease-resistant prion protein in prion-infected neuroblastoma cells. FEBS Lett 2010; 584: 1193-8.

  15. Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma- aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol 2008; 14: 7175-82.

  16. Takehara A, Hosokaway M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res 2007; 67: 9704-12.

  17. Johnson SK, Haun RS. The gamma-aminobutyric acid A receptors π subunit is overexpressed in pancreatic adenocarcinomas. JOP. J Pancreas (Online) 2005; 6: 136-42.

  18. Minuk GY, Zhang M, Gong Y, Minuk L, Dienes H, Pettigrew N, Kew M, et al. Decreased hepatocyte membrane potential differences and GABAA-beta3 expression in human hepatocellular carcinoma. Hepatology 2007; 45: 735-45.

  19. Moule SK, McGivan JD. Regulation of the plasma membrane potential in hepatocytes-mechanism and physiological significance. Biochim Biophys Act 1990; 1031: 383-97.

  20. Varro A, Lathrop DA, Hester SB, Nanasi PP, Papp JG. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol 1993; 88: 93-102.

  21. Sun D, Gong Y, Kojima H, Wang G, Ravinsky E, Zhang M, Minuk GY. Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth. Am J Physiol Gastrointest Liver Physiol 2003; 285: G12-G19.

  22. Lash AF, Falk G, Gerard RW. A microelectrode method in the diagnosis of carcinoma of the cervix and endometrium. Am J Obstet Gynecol 1955; 70: 354-8.

  23. Marino A, Iliev I, Schwalke MA, Gonzalez E, Marler K, Flanagan C. Association between cell membrane potential and breast cancer. Tumor Biol 1994; 15: 82-9.

  24. Picker S, Pieper CF, Goldring S. Glial membrane potentials and their relationship to [K+]o in man and guinea pig. J Neurosurg 1981; 55: 347-63.

  25. Tokuoka S, Morioka H. The membrane potential of the human cancer and related cells. Jpn J Cancer Res 1957; 48: 353-4.

  26. Perez-Tomas R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006; 13: 1859-76.

  27. Han B, Zhang JT. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2. Curr Med Chem Anticancer Agents 2004; 4: 31-42.

  28. Sundelacruz S, Levin M, Kaplan DL. Role of membrane potential in the regulation of cell proliferation and differentiation. Stem Cell Rev 2009; 5: 231-46.




2020     |     www.medigraphic.com